WIN55212-2 - Ligands - IUPHARBPS Guide to PHARMACOLOGY
win55 In five out of six primary MCLs, WIN55,212-2 induced a dose-dependent decreased cell viability, as assessed by flow cytometry, at 48 h. Half. WIN55,212-2 increases the proliferation of ipsilateral SVZ NG2-positive progenitor cells partially through CB1. In addition to the penumbral
Keunggulan win55
- ✅ win55 Setiap Hari
- ✅ Tanpa Deposit Awal
- ✅ Bisa Dicoba Gratis